[go: up one dir, main page]

GB0026738D0 - Diagnosis and therapeutic targeting of alzheimers disease in humans - Google Patents

Diagnosis and therapeutic targeting of alzheimers disease in humans

Info

Publication number
GB0026738D0
GB0026738D0 GB0026738A GB0026738A GB0026738D0 GB 0026738 D0 GB0026738 D0 GB 0026738D0 GB 0026738 A GB0026738 A GB 0026738A GB 0026738 A GB0026738 A GB 0026738A GB 0026738 D0 GB0026738 D0 GB 0026738D0
Authority
GB
United Kingdom
Prior art keywords
humans
diagnosis
alzheimers disease
therapeutic targeting
targeting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0026738A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METAGEN Ltd
Original Assignee
METAGEN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAGEN Ltd filed Critical METAGEN Ltd
Priority to GB0026738A priority Critical patent/GB0026738D0/en
Publication of GB0026738D0 publication Critical patent/GB0026738D0/en
Priority to EP04025899A priority patent/EP1538163A3/en
Priority to EP01980678A priority patent/EP1363939A2/en
Priority to US10/415,383 priority patent/US20040072753A1/en
Priority to PCT/GB2001/004843 priority patent/WO2002036614A2/en
Priority to AU2002212471A priority patent/AU2002212471A1/en
Ceased legal-status Critical Current

Links

GB0026738A 2000-11-01 2000-11-01 Diagnosis and therapeutic targeting of alzheimers disease in humans Ceased GB0026738D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0026738A GB0026738D0 (en) 2000-11-01 2000-11-01 Diagnosis and therapeutic targeting of alzheimers disease in humans
EP04025899A EP1538163A3 (en) 2000-11-01 2001-11-01 Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease
EP01980678A EP1363939A2 (en) 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease
US10/415,383 US20040072753A1 (en) 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease
PCT/GB2001/004843 WO2002036614A2 (en) 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease
AU2002212471A AU2002212471A1 (en) 2000-11-01 2001-11-01 Peptides for use in the treatment of alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0026738A GB0026738D0 (en) 2000-11-01 2000-11-01 Diagnosis and therapeutic targeting of alzheimers disease in humans

Publications (1)

Publication Number Publication Date
GB0026738D0 true GB0026738D0 (en) 2000-12-20

Family

ID=9902383

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0026738A Ceased GB0026738D0 (en) 2000-11-01 2000-11-01 Diagnosis and therapeutic targeting of alzheimers disease in humans

Country Status (1)

Country Link
GB (1) GB0026738D0 (en)

Similar Documents

Publication Publication Date Title
PT1334091E (en) Thioflavin derivatives and their use in diagnosis and therapy of alzheimer`s disease
AU2002303295B2 (en) Diagnosis and treatment of neural disease and injury using microvoltammetry
IL150628A0 (en) Use of lipid conjugates in the treatment of disease
HUP0401127A3 (en) Treatment and diagnosis of macrophage disease
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
HUP0500165A2 (en) Chalcone derivatives and their use to treat diseases
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001281369A1 (en) Cardiac disease treatment and device
AU2002327792A1 (en) Diagnosis and treatment of diseases caused by mutations in cd72
AU2002367535A8 (en) Diagnosis and treatment of vascular disease
AU2002346504A8 (en) Therapeutic protein and treatments
AU2002303261A8 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
IS6966A (en) Cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
IL151019A0 (en) Microcompetition and human disease
GB0026738D0 (en) Diagnosis and therapeutic targeting of alzheimers disease in humans
EP1322778A4 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2001253024A1 (en) Diagnosis and treatment of gastrointestinal disease
EP1409511A4 (en) DIAGNOSTIC AND THERAPEUTIC PRODUCTS AGAINST DOMESTIC AUTOSOMIC HEMOCHROMATOSIS
GB0026739D0 (en) Peptides for use in detection and therapeutic targeting of alzheimers disease
AU2000280405A1 (en) Targeting cells having mad2 mutation for treatment and/or prevention of disease
GB0029879D0 (en) Skin disease diagnosis and treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)